ICEBERG:インタールイキン-1β生成の新種の阻害剤
E W Humke1, S K Shriver, M A Starovasnik
1Department of Cellular and Molecular Biology, University of Michigan Medical School, Ann Arbor 48109, USA.
Cell
|October 29, 2000
まとめ
ICEBERGは,カスパース-1を結合することによって,炎症性サイトカインIL-1βの生成を抑制する新しいタンパク質です. この発見は,ICEBERGが炎症反応における負のフィードバックメカニズムとして作用することを示唆しています.
科学分野:
- 免疫学 免疫学とは
- 分子生物学は分子生物学である.
- 構造生物学 構造生物学とは
背景:
- 炎症を誘発するサイトカインIL-1βは,カスパース-1によって活性化されます.
- RIP2アダプタータンパク質は,炎症刺激に対するカスパース-1の自己活性化を促進する.
- IL-1βの産生を調節することは,炎症をコントロールするために非常に重要です.
研究 の 目的:
- IL-1β生成の新たなレギュレータを特定する.
- ICEBERGがIL-1βの生成を抑制するメカニズムを解明する.
- ICEBERG-caspase-1相互作用の構造的基礎を特徴づけるために.
主な方法:
- ICEBERGとカスパース-1との結合を評価するためのタンパク質相互作用の研究.
- ICEBERGの機能的役割を研究するために,レトロウイルスの発現を in vivo.
- X線結晶学により,ICEBERGの構造と,その複合体とカスパース-1との構造を決定する.
主要な成果:
- ICEBERGはcaspase-1に直接結合し,RIP2との結合およびその後の自動活性化を防ぐ.
- ICEBERGの発現は,炎症を誘発する刺激によって誘発され,負のフィードバックの役割を示しています.
- 強制的なICEBERG発現は,リポポリサッカリド誘発のIL-1β生成を抑制する.
- 構造分析により,ICEBERGは死亡ドメイン折りのスーパーファミリーに属し,電荷対電荷相互作用を通じてカスパーゼ-1プロドメインと相互作用することが明らかになった.
結論:
- ICEBERGは,カスパーゼ-1媒介型IL-1β産生を抑制する新薬です.
- ICEBERGは,炎症経路におけるネガティブなフィードバックの調節剤として機能します.
- 構造的補完性と課金補完性は,ICEBERGがCaspase-1に特異的に結びついていることを説明する.
関連する概念動画
Experimental RNAi
6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
897
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
897
Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Inhibitors of Bacterial Protein Synthesis
127
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Inhibitors of Bacterial DNA Synthesis
163
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
163
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73


